BACKGROUND. Liver disease is a frequent and major complication after organ transplantation. We sought to determine whether hepatitis C virus (HCV) is transmitted by organ transplantation and whether it causes post-transplantation liver disease. METHODS. Serum samples from all cadaver organ donors to the New England Organ Bank between 1986 and 1990 were screened retrospectively for antibodies to HCV (anti-HCV) by enzyme-linked immunosorbent assay (ELISA). We reviewed the hospital records of all recipients of organs from anti-HCV-positive donors for evidence of liver disease. Serum samples from recipients obtained before transplantation and during follow-up were analyzed for anti-HCV. RESULTS. Of 716 organ donors, 13 (1.8 percent) were positive for anti-HCV. Their organs (19 kidneys, 6 hearts, and 4 livers) went to 29 recipients. Non-A, non-B hepatitis developed after transplantation in 14 of the 29 (48 percent), for a prevalence 7.4 times the 6.5 percent prevalence after transplantation from untested donors that was previously reported by two institutions in the organ bank (P less than 0.0001). The liver disease began a mean of 3.8 months after transplantation and became chronic in 12 patients; the other 2 had subfulminant hepatic failure. Liver disease was more frequent in the patients who had received antilymphocyte preparations (P = 0.04). HCV was the cause of the post-transplantation liver disease in 12 of the 13 recipients (92 percent) for whom serum samples were available. Anti-HCV was detected by ELISA in eight and enzyme immunoassay in one; in three others, HCV RNA was detected by polymerase chain reaction in serum samples obtained after transplantation. CONCLUSIONS. Organ transplantation can transmit hepatitis C. This raises serious questions about the continued acceptance of organs from donors positive for anti-HCV.
Source Information
New England Organ Bank, Brookline, MA 02146.
This article has been cited by other articles:
Nwakanma, L. U., Shah, A. S., Conte, J. V., Baumgartner, W. A.
(2008). Heart Transplantation. Card Surg Adult
3: 1539-1578
[Full Text]
Delloye, C., Cornu, O., Druez, V., Barbier, O.
(2007). Bone allografts: WHAT THEY CAN OFFER AND WHAT THEY CANNOT. J Bone Joint Surg Br
89-B: 574-580
[Abstract][Full Text]
Wong, T., Lee, S. S.
(2006). Hepatitis C: a review for primary care physicians. CMAJ
174: 649-659
[Abstract][Full Text]
Tugwell, B. D., Patel, P. R., Williams, I. T., Hedberg, K., Chai, F., Nainan, O. V., Thomas, A. R., Woll, J. E., Bell, B. P., Cieslak, P. R.
(2005). Transmission of Hepatitis C Virus to Several Organ and Tissue Recipients from an Antibody-Negative Donor. ANN INTERN MED
143: 648-654
[Abstract][Full Text]
Abbott, K. C., Lentine, K. L., Bucci, J. R., Agodoa, L. Y., Koff, J. M., Holtzmuller, K. C., Schnitzler, M. A.
(2004). Impact of Diabetes and Hepatitis after Kidney Transplantation on Patients Who Are Affected by Hepatitis C Virus. J. Am. Soc. Nephrol.
15: 3166-3174
[Abstract][Full Text]
(2003). Hepatitis C Virus Transmission From an Antibody-Negative Organ and Tissue Donor--United States, 2000-2002. JAMA
289: 3235-3236
[Full Text]
Bethea, B. T., Yuh, D. D., Conte, J. V., Baumgartner, W. A.
(2003). Heart Transplantation. Card Surg Adult
2: 1427-1460
[Full Text]
Bucci, J. R., Matsumoto, C. S., Swanson, S. J., Agodoa, L. Y. C., Holtzmuller, K. C., Peters, T. G., Abbott, K. C.
(2002). Donor Hepatitis C Seropositivity: Clinical Correlates and Effect on Early Graft and Patient Survival in Adult Cadaveric Kidney Transplantation. J. Am. Soc. Nephrol.
13: 2974-2982
[Abstract][Full Text]
Ramos, E., Aoun, S., Harmon, W. E.
(2002). Expanding the Donor Pool: Effect on Graft Outcome. J. Am. Soc. Nephrol.
13: 2590-2599
[Full Text]
Blanche, C., Kamlot, A., Blanche, D. A., Kearney, B., Magliato, K. E., Czer, L. S. C., Trento, A.
(2002). Heart transplantation with donors fifty years of age and older. J. Thorac. Cardiovasc. Surg.
123: 810-815
[Abstract][Full Text]
Booth, J C L, O'Grady, J, Neuberger, J
(2001). Clinical guidelines on the management of hepatitis C. Gut
49: I1-21
[Full Text]
Schröter, M., Zöllner, B., Schäfer, P., Laufs, R., Feucht, H.-H.
(2001). Quantitative Detection of Hepatitis C Virus RNA by Light Cycler PCR and Comparison with Two Different PCR Assays. J. Clin. Microbiol.
39: 765-768
[Abstract][Full Text]
KASISKE, B. L., VAZQUEZ, M. A., HARMON, W. E., BROWN, R. S., DANOVITCH, G. M., GASTON, R. S., ROTH, D., SCANDLING, J. D. JR., SINGER, G. G.
(2000). Recommendations for the Outpatient Surveillance of Renal Transplant Recipients. J. Am. Soc. Nephrol.
11
: S1-S86
[Abstract][Full Text]
MORALES, J. M., CAMPISTOL, J. M.
(2000). Transplantation in the Patient with Hepatitis C. J. Am. Soc. Nephrol.
11: 1343-1353
[Full Text]
Schröter, M., Feucht, H.-H., Schäfer, P., Zöllner, B., Polywka, S., Laufs, R.
(1999). Definition of False-Positive Reactions in Screening for Hepatitis C Virus Antibodies. J. Clin. Microbiol.
37: 233-234
[Abstract][Full Text]
Johnson, M. W., Washburn, W. K., Freeman, R. B. Jr, FitzMaurice, S. E., Dienstag, J., Basgoz, N., Jenkins, R. L., Cosimi, A. B.
(1996). Hepatitis C Viral Infection in Liver Transplantation. Arch Surg
131: 284-291
[Abstract]
Morales, J. M., Andres, A., Campistol, J. M., Miller, J., Roth, D., Schiff, E. R., Candinas, D., Joller-Jemelka, H. I., Largiader, F., Pereira, B. J.G., Levey, A. S.
(1993). Hepatitis C Virus and Organ Transplantation. NEJM
328: 511-513
[Full Text]
Levinson, W. M., Wormser, G. P., Forseter, G., Calmann, M., O'Brien, T. A.
(1992). Hepatitis C Virus Seroprevalence in the Developmentally Disabled. Arch Intern Med
152: 2309-2311
[Abstract]
Roth, D., Fernandez, J. A., Babischkin, S., De Mattos, A., Buck, B.E., Quan, S., Olson, L., Burke, G. W., Nery, J. R., Esquenazi, V., Schiff, E. R., Miller, J.
(1992). Detection of Hepatitis C Virus Infection among Cadaver Organ Donors: Evidence for Low Transmission of Disease. ANN INTERN MED
117: 470-475
[Abstract]
Kirkland, L. R., Masor, J. J.
(1992). Passive Transfer of Antibody to Hepatitis C. Arch Intern Med
152: 639-640
[Abstract]
Previous
